What is the AbbVie Inc (ABBV) price today?

The price of AbbVie Inc (ABBV) today is $199.01. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Trade on Pluang

One platform for all markets

Download

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/ABBV

Buy & Sell AbbVie Inc (ABBV) – AbbVie Inc Price Today

Overview Financials Technicals Analysis Corp Action About

24H

YTD

Aura AI Summary

ABBV trades at $198.71, down 1.13% on the day, with a bearish technical signal from moving averages but oversold RSI levels. The company reported strong recent earnings beats, with Q2-Q4 2025 EPS exceeding expectations, and maintains robust profitability with a 70.24% gross margin. Revenue growth is supported by Skyrizi and Rinvoq, offsetting Humira declines, while cash flow trends show variability with a net outflow in 2024. Analyst consensus is bullish with a $254.36 price target, and recent news highlights pipeline advancements in oncology.

The outlook for ABBV is positive driven by product portfolio renewal and earnings momentum, though risks include patent cliffs in the 2030s and high debt levels. Investment appeal centers on dividend growth, with a $1.73 dividend declared for H1-26, and valuation metrics like a P/E of 83.84 suggest premium pricing that requires sustained execution to justify.

Read full analysis

Key Stats

Market Cap
$351.47B
Sector
Health
3M Drawdown
-15.87%
Enterprise Value
$413.71B
Dividend Yield
3.48%
Typical Hold Time
90 days

$199.01

52W Low: $177.44

14 May 2025

52W High: $244.38

01 Oct 2025

AbbVie Inc (ABBV) is currently valued at a market capitalization of $351.47B, with an enterprise value of $413.71B. Over the past 52 weeks, AbbVie Inc has traded between a low of $177.44 and a high of $244.38, highlighting its annual price range. Over the past three months, AbbVie Inc has recorded a drawdown of -15.87%, reflecting recent price volatility. AbbVie Inc offers a dividend yield of 3.48%, with the most recent dividend of $1.73 paid on 15 Apr 26. On average, investors hold AbbVie Inc for approximately 90 days, indicating typical investor behavior on the platform.

About AbbVie Inc

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

Technical Indicators

Overall Summary

Bearish (4)Neutral (10)Bullish (13)

News

Globe Newswire10 day ago

Non-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight

The Motley Fool11 day ago

3 High-Yielding Dividend Stocks to Buy, Even If You're Worried About the Market

Benzinga14 day ago

Eli Lilly's Jaypirca Builds Case With Fourth Positive Phase 3 Trial In Blood Cancer Patients

The Motley Fool14 day ago

S&P 500 Index Dividend Yields Are Teasing All-Time Lows. Here Are 3 Dividend Darlings That Crush This Trend.

Investing.com16 day ago

3 Companies Aggressively Raising Dividends While Others Play Defense

People also bought

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

Market Cap
$351.47B
Sector
Health
3M Drawdown
-15.87%
Enterprise Value
$413.71B
Dividend Yield
3.48%
Typical Hold Time
90 days

$199.01

52W Low: $177.44

14 May 2025

52W High: $244.38

01 Oct 2025

Let’s invest in this asset by signing up or download!

Buy & Sell AbbVie Inc (ABBV) – AbbVie Inc Price Today

Aura AI Summary

Key Stats

About AbbVie Inc

People also bought

Key Stats

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store